RxSight, Inc. (RXST)

USD 37.2

(-2.21%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 89.07 Million 49 Million 22.59 Million 14.67 Million 2.24 Million
Cost of Revenue 35.31 Million 27.67 Million 18.07 Million 12.97 Million 4.06 Million
Gross Profit 53.76 Million 21.32 Million 4.51 Million 1.7 Million -1.81 Million
Operating Expenses 103.85 Million 84.64 Million 57.3 Million 37.11 Million 44.77 Million
Selling, General and Administrative Expenses 74.79 Million 58.66 Million 32.8 Million 15.17 Million 15.2 Million
Research and Development Expenses 29.05 Million 25.98 Million 24.49 Million 21.93 Million 29.56 Million
Other Expenses - - - - -
Cost and Expenses 139.16 Million 112.32 Million 75.38 Million 50.08 Million 48.83 Million
Operating Income -50.08 Million -63.31 Million -52.78 Million -35.4 Million -46.07 Million
Interest Expense 3.3 Million 4.94 Million 3.68 Million 510 Thousand 26 Thousand
Income Tax Expense 20 Thousand 9000.00 8000.00 57 Thousand 24 Thousand
Earnings before Tax -48.58 Million -66.74 Million -48.68 Million 27.63 Million 126.24 Million
Net Income -48.6 Million -66.75 Million -48.68 Million 27.57 Million 126.22 Million
Earnings Per Share Basic -1.41 -2.41 -1.78 0.12 0.95
Earnings Per Share Diluted -1.41 -2.41 -1.78 0.12 0.95
Weighted Average Shares Outstanding 34.45 Million 27.66 Million 27.36 Million 27.62 Million 27.62 Million
Weighted Average Shares Outstanding (Diluted) 34.45 Million 27.66 Million 27.36 Million 27.62 Million 27.62 Million
Gross Margin 0.60 0.44 0.20 0.12 -0.81
EBIT Margin -0.46 -1.26 -2.33 -2.10 -18.01
Profit Margin -0.55 -1.36 -2.16 1.88 56.32
EBITDA -41.03 Million -57.77 Million -41.01 Million 32.15 Million 130.19 Million
Earnings Before Tax Margin -0.56 -1.29 -2.34 -2.41 -20.56

Income Statement Charts